IQVIA Cell and Gene Therapy Center
Fact Sheet
Driving stem cell development from candidate identification through market authorization

The focus in Regenerative Medicine (RMx) is changing from bench medicine to clinical-commercial success. RMx faces many headwinds: complex preclinical/nonclinical models, constrained clinical manufacturing capacity, limited clinical sites with RMx experience, shifting regulatory landscape and an unclear pathway for pricing and market access.

Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.